MedTrace Logo

Central China Congenital Heart Disease Associated Pulmonary Arterial Hypertension Cohort Study

NCT03977428 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2021-04-14

No results posted yet for this study

Summary

The study will recruit and follow up patients for five years patients newly diagnosed with congenital heart disease associated pulmonary arterial hypertension(CHD-PAH) from the investigator's hospital. The main aim of the study is to describe the aetiology, natural history and management practices of CHD-PAH in central China.

Conditions

Interventions

OTHER

standard of care

No intervention, this a patient registry and is purely an observational study

Sponsors & Collaborators

  • Wuhan Asia Heart Hospital

    lead OTHER

Principal Investigators

  • Qiu Qiu · Wuhan Asian Heart Hospital

Eligibility

Min Age
1 Year
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2022-12-30
Completion
2023-06-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03977428 on ClinicalTrials.gov